Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2015 2
2016 2
2017 2
2018 3
2019 7
2020 5
2021 6
2022 9
2023 11
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.
Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A, Seedat F, Koukounari A, Dangor Z, Leahy S, Santhanam S, John HB, Bramugy J, Bardají A, Abubakar A, Nasambu C, Libster R, Sánchez Yanotti C, Horváth-Puhó E, Sørensen HT, van de Beek D, Bijlsma MW, Gardner WM, Kassebaum N, Trotter C, Bassat Q, Madhi SA, Lambach P, Jit M, Lawn JE; GBS Danish and Dutch collaborative group for long term outcomes; GBS Low and Middle Income Countries collaborative group for long term outcomes; GBS Scientific Advisory Group, epidemiological sub-group; CHAMPS team. Gonçalves BP, et al. Lancet Glob Health. 2022 Jun;10(6):e807-e819. doi: 10.1016/S2214-109X(22)00093-6. Epub 2022 Apr 28. Lancet Glob Health. 2022. PMID: 35490693 Free PMC article.
Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022.
de Gier B, Marchal N, de Beer-Schuurman I, Te Wierik M, Hooiveld M; ISIS-AR Study Group; GAS Study group; de Melker HE, van Sorge NM; Members of the GAS study group; Members of the ISIS-AR study group. de Gier B, et al. Euro Surveill. 2023 Jan;28(1):2200941. doi: 10.2807/1560-7917.ES.2023.28.1.2200941. Euro Surveill. 2023. PMID: 36695447 Free PMC article.
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Monge S, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Sacco C, Mateo-Urdiales A, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Kristoffersen AB, Machado A, Soares P, Nardone A, Bacci S, Kissling E, Nunes B; VEBIS‐EHR Working Group. Monge S, et al. Among authors: de gier b. Influenza Other Respir Viruses. 2024 Apr;18(4):e13292. doi: 10.1111/irv.13292. Influenza Other Respir Viruses. 2024. PMID: 38654485 Free PMC article.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Fontán-Vela M, Kissling E, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Fabiani M, Mateo-Urdiales A, AlKerwi A, Schmitz S, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Starrfelt J, Nunes B, Caetano C, Derrough T, Nardone A, Monge S; VEBIS-Lot4 working group; VEBIS-Lot 4 working group. Fontán-Vela M, et al. Among authors: de gier b. Euro Surveill. 2024 Jan;29(1):2300670. doi: 10.2807/1560-7917.ES.2024.29.1.2300670. Euro Surveill. 2024. PMID: 38179626 Free PMC article.
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Huiberts AJ, Hoeve CE, de Gier B, Cremer J, van der Veer B, de Melker HE, van de Wijgert JH, van den Hof S, Eggink D, Knol MJ. Huiberts AJ, et al. Among authors: de gier b. Euro Surveill. 2024 Mar;29(10):2400109. doi: 10.2807/1560-7917.ES.2024.29.10.2400109. Euro Surveill. 2024. PMID: 38456217 Free PMC article.
[Invasive group A streptococcal infections in the Netherlands].
Vinkeles Melchers NVS, Nawijn F, Rümke LW, Dix LML, Vestjens SMT, Hietbrink F, Tjon-Kon-Fat R, Verspui-van der Eijk E, de Gier B, Vlaminckx BJM, Içli C, Quaak MSW, Huijskens EIGW. Vinkeles Melchers NVS, et al. Among authors: de gier b. Ned Tijdschr Geneeskd. 2023 Mar 16;167:D7118. Ned Tijdschr Geneeskd. 2023. PMID: 36928399 Dutch.
Disease burden of psittacosis in the Netherlands.
de Gier B, Hogerwerf L, Dijkstra F, van der Hoek W. de Gier B, et al. Epidemiol Infect. 2018 Feb;146(3):303-305. doi: 10.1017/S0950268817003065. Epub 2018 Jan 24. Epidemiol Infect. 2018. PMID: 29361998 Free PMC article.
Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.
Rümke LW, Davies MA, Vestjens SMT, van der Putten BCL, Bril-Keijzers WCM, van Houten MA, Rots NY, Wijmenga-Monsuur AJ, van der Ende A, de Gier B, Vlaminckx BJM, van Sorge NM. Rümke LW, et al. Among authors: de gier b. J Clin Microbiol. 2024 Oct 16;62(10):e0076624. doi: 10.1128/jcm.00766-24. Epub 2024 Aug 28. J Clin Microbiol. 2024. PMID: 39194268 Free PMC article.
57 results